Respiratory care
-
The patterns and kinetics of changes in SpO2 in the 6-min walk test (6MWT) and cycling test have not been addressed in patients with COPD. ⋯ Measurement of start-vs-nadir ΔSpO2 rather than start-vs-end ΔSpO2 during the 6MWT is recommended, because start-vs-nadir ΔSpO2 is greater, and the nadir SpO2 is earlier. In both the 6MWT and the cycling exercise test, desaturation can be predicted with the oxygen-cost-diagram score, which has more capability to predict peak exercise performance than the 6MWT.
-
Editorial Comment
Aerosol Administration During Nasal CPAP in Newborns Can Be Optimized.
-
Comment Letter
Furosemide Nebulization in Patients With COPD Exacerbation.
-
Randomized Controlled Trial Multicenter Study
Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group.
Tobramycin powder for inhalation (TIP) is a drug-device combination designed to reduce treatment time and improve ease of use compared with tobramycin inhalation solution (TIS) in cystic fibrosis (CF) patients. However, the ability of patients to use dry powder inhalers, and the efficacy of the treatments, may vary by age. ⋯ TIP is comparable to TIS in efficacy outcomes and safety profile but had greater patient satisfaction in all the age groups.